Literature DB >> 15950462

Active site binding modes of curcumin in HIV-1 protease and integrase.

Opa Vajragupta1, Preecha Boonchoong, Garrett M Morris, Arthur J Olson.   

Abstract

Structure models for the interaction of curcumin with HIV-1 integrase (IN) and protease (PR) were investigated using computational docking. Curcumin was found to bind preferentially in similar ways to the active sites of both IN and PR. For IN, the binding site is formed by residues Asp64, His67, Thr66, Glu92, Thr93, Asp116, Ser119, Asn120, and Lys159. Docked curcumin contacts the catalytic residues adjacent to Asp116 and Asp64, and near the divalent metal (Mg2+). In the PR docking, the curcumin structure fitted well to the active site, interacting with residues Asp25, Asp29, Asp30, Gly27', Asp29', and Asp30'. The results suggest that o-hydroxyl and/or keto-enol structures are important for both IN and PR inhibitory actions. The symmetrical structure of curcumin seems to play an important role for binding to the PR protein, whereas the keto-enol and only one side of the terminal o-hydroxyl showed tight binding to the IN active site.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950462     DOI: 10.1016/j.bmcl.2005.05.032

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  30 in total

1.  β-dicarbonyl enolates: a new class of neuroprotectants.

Authors:  Richard M LoPachin; Terrence Gavin; Brian C Geohagen; Lihai Zhang; Diana Casper; Rukmani Lekhraj; David S Barber
Journal:  J Neurochem       Date:  2010-12-02       Impact factor: 5.372

Review 2.  "Spicing up" of the immune system by curcumin.

Authors:  Ganesh Chandra Jagetia; Bharat B Aggarwal
Journal:  J Clin Immunol       Date:  2007-01-09       Impact factor: 8.317

Review 3.  Application of the Hard and Soft, Acids and Bases (HSAB) theory to toxicant--target interactions.

Authors:  Richard M Lopachin; Terrence Gavin; Anthony Decaprio; David S Barber
Journal:  Chem Res Toxicol       Date:  2011-11-16       Impact factor: 3.739

4.  Celastrol inhibits Tat-mediated human immunodeficiency virus (HIV) transcription and replication.

Authors:  Vivek Narayan; Kodihalli C Ravindra; Chris Chiaro; Daniele Cary; Bharat B Aggarwal; Andrew J Henderson; K Sandeep Prabhu
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

5.  Mechanism of isoproturon resistance in Phalaris minor: in silico design, synthesis and testing of some novel herbicides for regaining sensitivity.

Authors:  Durg Vijay Singh; Kuruba Adeppa; Krishna Misra
Journal:  J Mol Model       Date:  2011-07-15       Impact factor: 1.810

6.  Computational design of a full-length model of HIV-1 integrase: modeling of new inhibitors and comparison of their calculated binding energies with those previously studied.

Authors:  Selami Ercan; Necmettin Pirinccioglu
Journal:  J Mol Model       Date:  2013-08-02       Impact factor: 1.810

Review 7.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.

Authors:  Bharat B Aggarwal; Kuzhuvelil B Harikumar
Journal:  Int J Biochem Cell Biol       Date:  2008-07-09       Impact factor: 5.085

8.  Exploring the binding of HIV-1 integrase inhibitors by comparative residue interaction analysis (CoRIA).

Authors:  Devendra K Dhaked; Jitender Verma; Anil Saran; Evans C Coutinho
Journal:  J Mol Model       Date:  2008-12-02       Impact factor: 1.810

9.  Investigating the effect of gallium curcumin and gallium diacetylcurcumin complexes on the structure, function and oxidative stability of the peroxidase enzyme and their anticancer and antibacterial activities.

Authors:  Parisa Jahangoshaei; Leila Hassani; Fakhrossadat Mohammadi; Akram Hamidi; Khosro Mohammadi
Journal:  J Biol Inorg Chem       Date:  2015-09-14       Impact factor: 3.358

10.  Chitosan-alginate sponge: preparation and application in curcumin delivery for dermal wound healing in rat.

Authors:  Mei Dai; Xiuling Zheng; Xu Xu; Xiangye Kong; Xingyi Li; Gang Guo; Feng Luo; Xia Zhao; Yu Quan Wei; Zhiyong Qian
Journal:  J Biomed Biotechnol       Date:  2009-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.